Brief: Sellas Life Sciences Reports Full Year 2022 Financial Results And Provides Business Update
16/03/2023 21:33
March 16 (Reuters) - Sellas Life Sciences Group Inc
SLS.O :
* SELLAS LIFE SCIENCES REPORTS FULL YEAR 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* SELLAS LIFE SCIENCES GROUP INC - PHASE 3 REGAL GPS AML
STUDY ON
TRACK FOR INTERIM ANALYSIS BY LATE 2023/EARLY 2024
Source text for Eikon: ID:nGNX4kqfwx
Further company coverage: SLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sellas Life Sciences
See all newsBrief: Sellas Life Sciences Reaches 80Th Event In Phase 3 Regal Trial Of Galinpepimut-S (Gps) In Acute Myeloid Leukemia
SELLAS Life Sciences Q2 net loss widens on higher expenses
Brief: SELLAS Life Sciences Q2 Net Income USD -9.605 Million
Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SELLAS Life Sciences Q1 net loss widens on higher expenses